标题
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling
作者
关键词
-
出版物
Cancers
Volume 15, Issue 2, Pages 460
出版商
MDPI AG
发表日期
2023-01-11
DOI
10.3390/cancers15020460
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Caveolae-Associated Molecules, Tumor Stroma, and Cancer Drug Resistance: Current Findings and Future Perspectives
- (2022) Jin-Yih Low et al. Cancers
- Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
- (2022) Manan P. Shah et al. DRUGS
- Treatment Strategies and Outcomes for Patients with EGFR-mutant Non-Small Cell Lung Cancer Resistant to EGFR Tyrosine Kinase Inhibitors: Focus on Novel Therapies
- (2022) Melissa Johnson et al. LUNG CANCER
- Glioblastoma Treatment: State-of-the-Art and Future Perspectives
- (2022) Alejandro Rodríguez-Camacho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer
- (2021) Fatemeh Moosavi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Exploring liver cancer biology through functional genetic screens
- (2021) Cun Wang et al. Nature Reviews Gastroenterology & Hepatology
- High-density lipoproteins and immune response: A review
- (2021) Elena Grao-Cruces et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Pichia pastoris : A highly successful expression system for optimal synthesis of heterologous proteins
- (2020) Mohsen Karbalaei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Safety and Tolerability of c-MET Inhibitors in Cancer
- (2019) Alberto Puccini et al. DRUG SAFETY
- Cellular origin of glioblastoma and its implication in precision therapy
- (2018) Maojin Yao et al. Cellular & Molecular Immunology
- Pharmacodynamic endpoints as clinical trial objectives to answer important questions in oncology drug development
- (2016) Ralph E. Parchment et al. SEMINARS IN ONCOLOGY
- Endoplasmic Reticulum Stress-Activated Cell Reprogramming in Oncogenesis
- (2015) E. Chevet et al. Cancer Discovery
- Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032
- (2015) Elisabetta Vergani et al. NEOPLASIA
- The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
- (2014) Francesco Passiglia et al. CURRENT DRUG TARGETS
- Processed pseudogenes acquired somatically during cancer development
- (2014) Susanna L. Cooke et al. Nature Communications
- Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
- (2013) C. Atkins et al. CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Microdomains in the membrane landscape shape antigen-presenting cell function
- (2013) Malou Zuidscherwoude et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
- (2012) Fadila Guessous et al. Anti-Cancer Agents in Medicinal Chemistry
- Lipid-dependent protein sorting at the trans-Golgi network
- (2012) Michal A. Surma et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Targeted Disruption of Heparan Sulfate Interaction with Hepatocyte and Vascular Endothelial Growth Factors Blocks Normal and Oncogenic Signaling
- (2012) Fabiola Cecchi et al. CANCER CELL
- The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype
- (2012) F. De Bacco et al. CANCER RESEARCH
- MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells
- (2012) C.-T. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
- (2011) Inna V. Fedorenko et al. BIOCHEMICAL PHARMACOLOGY
- Hedgehog Fights Back: Mechanisms of Acquired Resistance against Smoothened Antagonists
- (2011) C. Metcalfe et al. CANCER RESEARCH
- c-Met inhibitors with different binding modes: Two is better than one
- (2011) Isabelle Dussault et al. CELL CYCLE
- Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort
- (2011) Seiji Yano et al. Journal of Thoracic Oncology
- Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer
- (2011) Tadaaki Yamada et al. Journal of Thoracic Oncology
- EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
- (2011) Michela Garofalo et al. NATURE MEDICINE
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma
- (2011) Q. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor-Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid Tumors
- (2010) M. S. Gordon et al. CLINICAL CANCER RESEARCH
- Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer
- (2010) K. Suda et al. CLINICAL CANCER RESEARCH
- Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
- (2010) Ian M. Buchanan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor
- (2010) T. L. Burgess et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms of the origin of micronuclei from extrachromosomal elements
- (2010) N. Shimizu MUTAGENESIS
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
- (2010) Laura Poliseno et al. NATURE
- Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors
- (2009) Alessandro A. Boezio et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
- (2009) Philippe Bedard et al. CURRENT CANCER DRUG TARGETS
- Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer
- (2009) Jihong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value
- (2009) Roberto Garcia-Navarrete et al. JOURNAL OF NEURO-ONCOLOGY
- Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma
- (2009) C.-F. Gao et al. MOLECULAR CANCER THERAPEUTICS
- MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
- (2008) F. Cappuzzo et al. ANNALS OF ONCOLOGY
- Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
- (2008) D. L. Shattuck et al. CANCER RESEARCH
- Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
- (2008) S. Yano et al. CANCER RESEARCH
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now